Carindacillin
Systematic (IUPAC) name | |
---|---|
(2S,5R,6R)-6-([3-(2,3-dihydro-1H-inden-5-yloxy)-3-oxo-2-phenylpropanoyl]amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 26605-69-6 |
ATC code | J01CA05 (WHO) |
PubChem | CID 93184 |
ChemSpider | 391995 |
UNII | 5V278481KE |
ChEMBL | CHEMBL1200991 |
Chemical data | |
Formula | C26H26N2O6S |
Molar mass | 494.55 g/mol |
|
Carindacillin (INN), also known as Carbenicillin indanyl (USAN) is a penicillin antibiotic. It is a prodrug of carbenicillin.[1]
It is administered orally, as the sodium salt. It is no longer marketed in the United states, but used to be marketed by Pfizer under the brand name Geocillin.
References
- ↑ English AR, Retsema JA, Ray VA, Lynch JE (March 1972). "Carbenicillin indanyl sodium, an orally active derivative of carbenicillin". Antimicrob. Agents Chemother. 1 (3): 185–91. doi:10.1128/aac.1.3.185. PMC 444190. PMID 4558137.
|
This article is issued from Wikipedia - version of the Tuesday, April 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.